Table 2.

Global orphan drugs demand by value, 2005–2011 ($, million)

	2005	2006	2011	CAGR (%) 2006–2011
Biologics	30,200	35,300	53,400	9
Nonbiologics	24,300	23,400	28,400	4
Total	54,500	58,700	81,800	7